Directional Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$690K Buy
575
+71
+14% +$72.5K 0.58% 45
2026
Q1
$464K Buy
504
+201
+66% +$204K 0.42% 59
2025
Q4
$326K Buy
+303
New +$290K 0.29% 69

Other funds holding LLY

Directional Asset Management's LLY Position: Q2 2026 in Review

Directional Asset Management increased its Eli Lilly (LLY) stake by 14% in Q2 2026, buying an estimated $72.5K and bringing the position to 575 shares worth $690K. The position accounts for 0.58% of the portfolio, ranked #45.

Directional Asset Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,594 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Directional Asset Management held 575 shares of Eli Lilly worth $690K as of Q2 2026.
  • Directional Asset Management bought 71 Eli Lilly shares in Q2 2026, an estimated $72.5K.
  • Eli Lilly made up 0.58% of Directional Asset Management's portfolio in Q2 2026, its #45 holding.
  • Directional Asset Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Directional Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.